Enhancement of dissolution and bioavailability of ezetimibe by amorphous solid dispersion nanoparticles fabricated using supercritical antisolvent process

Baek IH, Kim MS (2012) Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions. Chem Pharm Bull 60:1468–1473

Bakhbakhi Y, Charpentier PA, Rohani S (2006) Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery. Int J Pharm 309:71–80

Bali V, Ali M, Ali J (2010) Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloid Surf B 76:410–420

Bali V, Ali M, Ali J (2011) Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm 403:46–56

Bandyopadhyay S, Katare OP, Singh B (2012) Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloid Surf B 100:50–61

Cho Y, Ha ES, Baek IH, Kim MS, Cho CW, Hwang SJ (2015) Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® E. Molecules 20:9496–9509

Dixit RP, Nagarsenker MS (2008) Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Euro J Pharm Sci 35:183–192

Esfandiari N (2015) Production of micro and nano particles of pharmaceutical by supercritical carbon dioxide. J Supercrit Fluids 100:129–141

Friedman HS, Rajagopalan S, Barnes JP, Roseman H (2011) Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. Clin Ther 33:212–224

Gao P, Shi Y (2012) Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs. AAPS J 14:703–713

Gulsun T, Gursoy RN, Oner L (2011) Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull 59:41–45

Ha ES, Baek IH, Cho W, Hwang SJ, Kim MS (2014a) Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique. Chem Pharm Bull 62:545–551

Ha ES, Choo GH, Baek IH, Kim MS (2014b) Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process. Molecules 19:20325–20339

Juppo AM, Boissier C, Khoo C (2003) Evaluation of solid dispersion particles prepared with SEDS. Int J Pharm 250:385–401

Khan KA, Rhodes CT (1972) Effect of compaction pressure on the dissolution efficiency of some direct compression systems. Pharm Acta Helv 47:594–607

Kim MS (2013) Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures. Int J Nanomedicine 8:2029–2039

Kim MS, Baek IH (2014) Fabrication and evaluation of valsartan polymer surfactant composite nanoparticles using supercritical antisolvent process. Int J Nanomedicine 9:5167–5176

Kim MS, Lee S, Park JS, Woo JS, Hwang SJ (2007) Micronization of cilostazol using supercritical antisolvent (SAS) process: effect of process parameters. Powder Technol 177:64–70

Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ (2008) Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Euro J Pharm Biopharm 69:454–465

Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ (2011) Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Int J Nanomedicine 6:2997–3009

Kim MS, Song HS, Park HJ, Hwang SJ (2012) Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process. Chem Pharm Bull 60:543–547

Kim MS, Kim JS, Cho W, Cha KH, Park HJ, Park J, Hwang SJ (2013) Supersaturatable formulations for the enhanced oral absorption of sirolimus. Int J Pharm 445:108–116

Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB (2005) Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44:467–494

Lee JY, Kang WS, Piao J, Yoon IS, Kim DD, Cho HJ (2015) Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Drug Des Dev Ther 9:2745–2756

Oswald S, Scheuch E, Cascorbi I, Siegmund W (2006) A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1. J Chromatogr B 830:143–150

Patel R, Bhimani D, Patel J, Patel D (2008) Solid-state characterization and dissolution properties of ezetimibe–cyclodextrins inclusion complexes. J Incl Phenom Macrocycl Chem 60:241–251

Paudel A, Worku ZA, Meeus J, Guns S, Van den Mooter G (2013) Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 453:253–284

Rashid R, Kim DW, Din FU, Mustapha O, Yousaf AM, Park JH, Kim JO, Yong CS, Choi HG (2015) Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym 130:26–31

Reverchon E, Marco ID, Porta GD (2002) Tailoring of nano- and micro-particles of some superconductor precursors by supercritical antisolvent precipitation. J Supercrit Fluids 23:81–87

Sancheti PP, Karekar P, Vyas VM, Shah M, Pore YV (2009) Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie 64:227–231

Secuianu C, Feroiu V, Geanǎ D (2008) Phase behavior for carbon dioxide + ethanol system: experimental measurements and modeling with a cubic equation of state. J Supercrit Fluids 47:109–116

Taupitz T, Dressman JB, Klein S (2013) New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Euro J Pharm Biopharm 84:208–218

Yasuji T, Takeuchi H, Kawashima Y (2008) Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv Drug Deliv Rev 60:388–398

Yin X, Daintree LS, Ding S, Ledger DM, Wang B, Zhao W, Qi J, Wu W (2015) Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Drug Des Dev Ther 9:2801–2810